共 19 条
- [1] Optim izing the hybrid capture II human pap illomavirus test to detect cervical intraep ithelial neoplasia. HowardM,Sellors J,Kaczorowski J. Obstetrics and Gynecology . 2002
- [2] Human pap illoma virus and cervical screening. Damasus-Awatai G,Freeman-W ang T. CurrOp in ObstetGynecol . 2003
- [3] Population-based study of human pap illomavirus infection and cervical neoplasia in rural Costa R ica. Herrero R,H ildesheim A,Bratti C,et al. Journal of the National Cancer Institute . 2000
- [4] 2001 consensus guidelines for the management of women with cervical intraep ithelial neoplasia. W rightTC Jr,Cox JT,Massad LS,et al. American Journal of Obstetrics and Gynecology . 2003
- [5] Usefulness of human pap illoma virus testing in the screening of cervical cancer precursor lesions: a retrospective study in 314 cases. Infantolino C,Fabris P,Infantolino D,et al. European Journal of Obstetrics and Gynecology . 2000
- [6] HPV-based cervical cancer screening in a population at high risk forHIV infection. W omack SD,Chirenje ZM,Gaffikin L,et al. International Journal of Cancer . 2000
- [7] Human pap illomavirus and cervical cancer. Burd EM. C lin M icrobiol Rev . 2003
- [8] The causal relation between human pap illomavirus and cervical cancer. Bosch FX,Lorincz A,Munoz N,et al. Journal of Clincal Pathology . 2002
- [9] Human pap illomavirus DNA testing for cervical cancer screening in low-resource settings. Kuhn L,Denny L,Pollack A,et al. Journal of the National Cancer Institute . 2000
- [10] Prevalence and predictors of human pap illomavirus infection in women in Ontario, Canada.Survey ofHPV in Ontario W omen ( SHOW ) Group. Sellors JW,Mahony JB,Kaczorowski J,et al. Canadian Medical Association Journal . 2000